Hirayama disease associated with neurogenic bladder dysfunction

Affiliations

¹ Queen Elizabeth Hospital, Lewisham & Greenwich NHS Trust, London, UK. osman.younus@nhs.net.
² Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, UK.
³ Frimsley Park Hospital, Frimsley Health NHS Foundation Trust, Surrey, UK.
⁴ Queen Elizabeth Hospital, Lewisham & Greenwich NHS Trust, London, UK.

Osman Younus et al. Acta Neurol Belg. 2023 Apr.

. 2023 Apr;123(2):675-677.

doi: 10.1007/s13760-022-01951-y. Epub 2022 Apr 14.

¹ Queen Elizabeth Hospital, Lewisham & Greenwich NHS Trust, London, UK. osman.younus@nhs.net.
² Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, UK.
³ Frimsley Park Hospital, Frimsley Health NHS Foundation Trust, Surrey, UK.
⁴ Queen Elizabeth Hospital, Lewisham & Greenwich NHS Trust, London, UK.

No abstract available

References

1. Wang H, Zheng C, Jin X, Lyu F, Ma X, Xia X et al (2019) The Huashan diagnostic criteria and clinical classification of Hirayama disease. Chin J Orthop 39:458–465
1. Fujimori T, Tamura A, Miwa T, Iwasaki M, Oda T (2017) Severe cervical flexion myelopathy with long tract signs: a case report and a review of literature. Spinal Cord Series and Cases 3(1):17016 - DOI - PubMed - PMC
1. Sobue I, Saito N, Iida M, Ando K (1978) Juvenile type of distal and segmental muscular atrophy of upper extremities. Ann Neurol 3(5):429–432 - DOI - PubMed
1. Khandelwal D, Bhatia M, Vivekanandan S, Singh S, Shukla G, Goyal V et al (2006) IgM anti-GM1 antibody titers in patients with monomelic amyotrophy. Neurol India 54:399–401 - DOI - PubMed
1. Cerami C, Valentino F, Piccoli F, La Bella V (2008) A cervical myelopathy with a Hirayama disease-like phenotype. Neurol Sci 29(6):451–454 - DOI - PubMed